2012～2016年本院抗糖尿病药物的调查研究分析

Investigation and analysis of anti diabetic drugs in our hospital during 2012 to 2016

目的 对本院2012-2016年抗糖尿病药物的使用情况进行调查研究分析,为临床用药提供依据.方法 收集本院2012-2016年抗糖尿病药物的药物名称、生产厂家、规格用量、数量、金额等,用Excel 2007进行数据处理,计算用药频度（DDDs）及日均费用（DDC）.结果 从2012-2016年,本院抗糖尿病药物的总花费金额从1231.15万元上升至1946.78万元,增长了58.13%.消费金额占前三位的抗糖尿药物为胰岛素、磺酰脲类、双胍类;DDDs前三位为胰岛素、磺酰脲类、α-糖苷酶抑制剂;DDC最高的3种药物为依帕司他片、甘精胰岛素注射液、门冬胰岛素30注射液.结论 本院2012-2016年治疗糖尿病药物使用情况较为合理,胰岛素类药物用量大,一些新型口服所占比重不断增加.

Objective To use in our hospital during 2012 to 2016 anti diabetic drugs were investigated in the analysis, and provide the basis for clinical treatment.MethodsThe drug collected in our hospital during 2012 to 2016 anti diabetic drug name, manufacturer, specifications, quantity, amount, amount, using Excel 2007 for data processing, calculation of DDDs （DDDs） and daily cost （DDC）.ResultsFrom 2012 to 2016, the antidiabetic drugs in our hospital the total expenses increased from 12 million 311 thousand and 500 yuan to 19 million 467 thousand and 800 yuan, up 58.13% The amount of consumption.The top three anti diabetic drugs for insulin, sulfonylurea, biguanides;DDDs three for insulin, sulfonylureas, alpha glucosidase inhibitors;DDC three drugs was the highest in Epalrestat Tablets, Insulin Glargine Injection, Insulin Aspart 30 Injection.ConclusionThe treatment of diabetes in our hospital during 2012 to 2016 drug use is more reasonable, the insulin dosage, some new oral proportion is increasing.